Managing Atrial Fibrillation In The Older Patient

Moderator: Michael W. Rich, MD
This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.
Learning Objectives: (1) discuss the recommendations of the American College of Cardiology (ACC), the American Heart Association (AHA) and the European Society of Cardiology (ESC) Guidelines and their effectiveness in managing AF to prevent stroke; (2) discuss the risks and benefits of treatment options, including warfarin alternatives; (3) describe the co-morbidities and geriatric syndromes common among older adults with AF and understand the need to take an individualized management approach to care; and (4) manage AF pharmacologically with the awareness of polypharmacy issues. 

Can the ACC/AHA/ESC Guidelines Improve the Management of Atrial Fibrillation?
Thomas A. Burkart, MD, FACC

Pharmacological Treatment of AF beyond Warfarin
Sean M. Jeffery, PharmD

Management of Older Patients Diagnosed with AF and Multiple Comorbidities
Mark A. Supiano, MD